Back to Invesco Ltd. Invesco Ltd.

SXTCSXTC
3 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in China SXT Pharmaceuticals, Inc.

No. Invesco exited its SXTC (China SXT Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 85,331 shares worth $136,530. Invesco first reported SXTC in Q3 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$140,766

Total Shares Change

-89,660

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$13,440.00
0
2025-Q4
Decreased
85,331
-4.8%
$136,5300.0%$1,920,000.00
0
2025-Q3
New
89,660
-
$140,7660.0%$1,884,000.00
34

Other major holders of SXTC: CITADEL ADVISORS LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used